Anticoagulation and heart valve prosthesis;L'anticoagulazione nei pazienti portatori di protesi valvolari cardiache

Monaldi Archives for Chest Disease

Volumn 58, Issue 2, 2002, Pages 121-127

  Calisi, P ^a   Griffo, R ^a  

^a Ospedale La Colletta   (Italy)

Author keywords

Artificial heart valve; Oral anticoagulants; Thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; HEPARIN; PHENPROCOUMON; VITAMIN K GROUP; WARFARIN;

ANTICOAGULANT THERAPY; ANTICOAGULATION; BLEEDING; CARDIOVASCULAR PROCEDURES; CARDIOVASCULAR RISK; CHONDRODYSPLASIA PUNCTATA; DRUG FATALITY; EMBRYOPATHY; FETUS DEATH; HEART SURGERY; HEART VALVE PROSTHESIS; HUMAN; INTERNATIONAL STANDARD UNIT; MATERNAL DISEASE; MATERNAL MORTALITY; MICROCEPHALY; OSTEOPOROSIS; PATHOGENESIS; PATIENT CARE; PREGNANCY; PRIMIGRAVIDA; PROSTHESIOLOGY; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT; SOLUTIO PLACENTAE; SPONTANEOUS ABORTION; THROMBOCYTOPENIA; THROMBOEMBOLISM; VALVULAR HEART DISEASE; RISK FACTOR;

ANTICOAGULANTS; HEART VALVE PROSTHESIS; HUMANS; RISK FACTORS; THROMBOEMBOLISM;

EID: 0036718869     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Leguerrier A, Tixier D, Corbineau H, Langanay T. Prothèses valvulaires cardiaques. Encycl Méd Chir. Editions Scientifiques et Médicales Elsevier SAS, Paris, 2001: 1-20.
2. Grunkemeier GL, Starr A, Rahimtoola SH. - Prosthetic hear valve performance: Long-term follow-up. Curr Prob Cardiol 1992; 17: 331-406.
3. ACC/AHA Task Force on Practice Guidelines. - Guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol 1998; 32: 1486-1588.
4. Respighi E, Tarelli G, Belli G, Ferrarese S. - Sostituti protesici valvolari aortici: Criteri di scelta. In: Cardiologia 1996. Atti del 30° Convegno Internazionale del Dipartimento Cardiologico e Cardiochirurgico A. De Gasperis.
5. Butchart EG. - Prosthetic heart valves. In: Education Programme on Difficult Situations in the Management of Valvular Disease. European Heart House. March 29-31, 2001.
6. Gohlke-Bärwolf C. - Anticoagulation during extra cardiac surgery. In: Education Programme on Difficult Situations in the Management of Valvular Disease. European Heart House. March 29-31, 2001.
7. Pengo V, Prisco D, Iliceto S. - Gestione attuale della terapia anticoagulante orale. Ital Heart J 2002; 3 (5): 502-517.
8. Mc Anulty, Rahimtoola SH. Terapia antitrombotica e valvulopatie. In: Wayne Alexander R, Schlant RC, Fuster V, eds. Hurst. Il Cuore. Mc Graw-Hill Libri Italia srl, 1998: 2095-2103.
9. Stein PD, Alpert JS, Bussey HI, Dalen JE, Turpie AGG. - Terapia antitrombotica nei pazienti con protesi valvolari cardiache meccaniche e biologiche. Chest Edizione Italiana 2001; 119: 220S-227S.
10. Stein PD, Dalen JE, Goldman S, Théroux P. - Terapia antitrombotica nei pazienti portatori di bypass aortocoronarici con vena safena e con arteria mammaria interna. Chest Edizione Italiana 2001; 119: 278S-282S.
11. Ciani R. - Protesi valvolari cardiache e gestione del valvulopatico operato. In: Trattato di Cardiologia ANMCO. Excerpta Medica.
12. Iung B. - When should we add Aspirin to Coumadin? In: Education Programme on Difficult Situations in the Management of Valvular Disease. European Heart House. March 29-31, 2001.
13. Butchart EG, Lewis PA, Grunkemeier GL, Kulatilake N, Breckenridge IM. - Low risk of thrombosis and serious embolic events despite low-intensity anticoagulation: Experience with 1004 Medtronic Hall valves. Circulation 1998; 78 (suppl I): 66-77.
14. Butchart EG. - Thrombogenicity, thrombosis and embolism. In: Butchart EG, Bodnar E, eds. Current Issues in Heart Valve Disease: Thrombosis, Embolism and Bleeding. London: ICR, 1992: 172-205.
15. Bodnar E. - The Medtronic Parallel valve and the lessons learned. J Heart Valve Dis 1996; 5: 572-573.
16. Braunwald E. Valvular heart disease. In: Braunwald E, Zipes DP, Libby P, eds. Heart Disease. A Textbook of Cardiovascular Medicine. Philadelphia, PA: WB Saunders, 2001: 1643-1722.
17. Turpie AGG. - Antithrombotic theraphy after heart valve replacement. In: Yusuf S, Cairns AJ, Camm AJ, Fallen EL, Gersh BJ, eds. Evidence Based Cardiology. London. BMJ Books 1999: 905-911.
18. Massel D, Little SH. - Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: A meta-analysis. J Am Coll Cardiol 2001; 37 (2): 569-578.
19. Schaff HV. Protesi valvolari. In: Giuliani ER, Gersh BJ, McGoon MD, Hayes DL, Schaff HV, eds. Mayo Clinic la Pratica della Cardiologia. Mosby Italia srl, 1999: 1486-1498.
20. Stein PD, Alpert JS, Dalen JE. - Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 1998; 114: 602S-610S.
21. Hancock EW. Malattie delle valvole artificiali. In: Schlant RC, Wayne Alexander R, eds. Hurst il Cuore. McGraw-Hill Libri Italia srl, 1994: 1663-1669.
22. Gohlke-Bärwolf C. - Anticoagulation during pregnancy in patients with valvular heart diseases, valve-prostheses, venous thrombosis, pulmonary emboli or atrial fibrillation - Fetal risks versus maternal thromboemboli. In: Education Programme on Difficult Situations in the Management of Valvular Disease. European Heart House. March 29-31, 2001.
23. Oakley CM. - Anticoagulation and pregnancy. Eur Heart J 1995; 16: 1317-1319.
24. Scardi S, Mazzone C. Nuovi modelli operativi per la gestione della profilassi anticoagulante. Monaldi Arch Chest Dis 2002; 58: 1, 64-69.